BR9612245A - Inibidor de óxido nitrico (no) sintase para tratamento ou prevenção de diabetes tipo ii - Google Patents

Inibidor de óxido nitrico (no) sintase para tratamento ou prevenção de diabetes tipo ii

Info

Publication number
BR9612245A
BR9612245A BR9612245A BR9612245A BR9612245A BR 9612245 A BR9612245 A BR 9612245A BR 9612245 A BR9612245 A BR 9612245A BR 9612245 A BR9612245 A BR 9612245A BR 9612245 A BR9612245 A BR 9612245A
Authority
BR
Brazil
Prior art keywords
diabetes
treatment
type
synthase inhibitor
prevention
Prior art date
Application number
BR9612245A
Other languages
English (en)
Inventor
Micholas Charles Turner
Valerie Piercy
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR9612245A publication Critical patent/BR9612245A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
BR9612245A 1995-12-22 1996-12-18 Inibidor de óxido nitrico (no) sintase para tratamento ou prevenção de diabetes tipo ii BR9612245A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9526331.5A GB9526331D0 (en) 1995-12-22 1995-12-22 Novel method
PCT/EP1996/005871 WO1997023204A1 (en) 1995-12-22 1996-12-18 Nitric oxide (no) synthase inhibitor to treat or prevent type ii diabetes

Publications (1)

Publication Number Publication Date
BR9612245A true BR9612245A (pt) 1999-07-13

Family

ID=10785930

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9612245A BR9612245A (pt) 1995-12-22 1996-12-18 Inibidor de óxido nitrico (no) sintase para tratamento ou prevenção de diabetes tipo ii

Country Status (20)

Country Link
EP (1) EP0868175B1 (pt)
JP (1) JP2000502668A (pt)
KR (1) KR19990076595A (pt)
CN (1) CN1209057A (pt)
AT (1) ATE232724T1 (pt)
AU (1) AU1379497A (pt)
BR (1) BR9612245A (pt)
CA (1) CA2240396A1 (pt)
CZ (1) CZ198698A3 (pt)
DE (1) DE69626307T2 (pt)
ES (1) ES2193285T3 (pt)
GB (1) GB9526331D0 (pt)
HU (1) HUP9903979A3 (pt)
IL (1) IL124870A0 (pt)
MX (1) MX9805098A (pt)
NO (1) NO982854L (pt)
NZ (1) NZ325307A (pt)
PL (1) PL327472A1 (pt)
TR (1) TR199801133T2 (pt)
WO (1) WO1997023204A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999044598A2 (en) * 1998-03-03 1999-09-10 Board Of Regents, The University Of Texas System Methods for inhibiting βcell apoptosis
CN1660428B (zh) * 2005-01-10 2011-09-07 王振军 一氧化氮合酶（nos）抑制剂用于治疗痔的新用途
ES2386831B1 (es) * 2011-02-04 2013-07-08 Servicio Andaluz De Salud Uso de inhibidores de la actividad de las NO sintasas (NOS) y sus composiciones, en la elaboración de un medicamento para el tratamiento y la prevención de la prediabetes y la diabetes mellitus tipo 1 (DM1)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT793646E (pt) * 1994-11-23 2002-03-28 Biovitrum Ab Carboxilatos de aminoguanidina destinados ao tratamento de diabetes mellitus nao-insulinodependente

Also Published As

Publication number Publication date
NZ325307A (en) 1999-11-29
DE69626307T2 (de) 2003-10-16
CA2240396A1 (en) 1997-07-03
DE69626307D1 (de) 2003-03-27
EP0868175B1 (en) 2003-02-19
EP0868175A1 (en) 1998-10-07
NO982854D0 (no) 1998-06-19
MX9805098A (es) 1998-10-31
AU1379497A (en) 1997-07-17
PL327472A1 (en) 1998-12-07
HUP9903979A2 (hu) 2000-03-28
HUP9903979A3 (en) 2000-05-29
TR199801133T2 (xx) 1998-09-21
ES2193285T3 (es) 2003-11-01
CN1209057A (zh) 1999-02-24
ATE232724T1 (de) 2003-03-15
JP2000502668A (ja) 2000-03-07
IL124870A0 (en) 1999-01-26
WO1997023204A1 (en) 1997-07-03
NO982854L (no) 1998-06-19
CZ198698A3 (cs) 1999-06-16
GB9526331D0 (en) 1996-02-21
KR19990076595A (ko) 1999-10-15

Similar Documents

Publication Publication Date Title
AP9801272A0 (en) Use of an antagonist of ppar-alpha and ppr-gamma for the treatment of syndrom X.
DK1169060T3 (da) Natriumkanalblokkerpræparater og anvendelse deraf
MXPA04006039A (es) Metodo para el tratamiento de afecciones vasculares y neuronales perifericas.
BR9811099A (pt) Inibidores de urocinase
MX9304435A (es) Compuesto y composicion farmaceutica para el tratamiento y la profilaxis de la obesidad o para el tratamiento de la diabetes del tipo ii.
GR3031917T3 (en) Treatment of diseases caused by sebaceous gland disorders with acyl CoA cholesterol acyl transferase inhibitors
WO2002005642A3 (en) Synergistic biocidal compositions
NO20011757L (no) Reversering av viral-indusert systemisk sjokk og åndenöd ved blokkering av lymfotoksin-<beta>-veien
MX9707278A (es) Derivados tipo mercapto y seleno como inhibidores de la oxido nitrico sintasa.
BR0212989A (pt) Métodos para tratamento neuroprotetor usando inibidores de inos seletivos
SE0004101D0 (sv) New use
BR9612245A (pt) Inibidor de óxido nitrico (no) sintase para tratamento ou prevenção de diabetes tipo ii
WO2002096870A3 (en) Sponge-derived terpenoids and methods of use
EP0345948A3 (en) Use of 5-HT1A agonists for the manufacture of a medicament protecting against ischaemic damage
EP0974351A3 (en) Medicament for preventing and treating gastrointestinal damage
AU4937499A (en) Use of succinic acid or salts thereof and method of treating insulin resistance
WO2001068066A3 (en) A composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
NO982853D0 (no) Aminoguanidin for behandling av NIDDM
BR0313204A (pt) Métodos para tratamento e prevenção de condições gastrointestinais
WO2003077831A3 (en) Compositions and methods for treating mdma-induced toxicity
PT971714E (pt) Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia
UA23061A (uk) Композиція для лікуваhhя і профілактики ектопаразитарhих хвороб твариh
EP0663211A4 (en) AGENT FOR PREVENTION AND TREATMENT OF DIGESTIVE APPARATUS MUCOUS DISORDERS.
UA32146A (uk) Спосіб оцінки ефективності лікування пародонтита

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]